Glassman Wealth Services Teva Pharmaceutical Industries LTD Transaction History

Glassman Wealth Services

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$8.12 - $10.63 $8 - $10	1 Added 0.14%	707 $7,000
Q3 2023 Nov 13, 2023	BUY	$7.48 - $10.7 $2,057 - $2,942	275 Added 63.81%	706 $7,000
Q2 2023 Aug 08, 2023	SELL	$7.2 - $9.47 $439 - $577	-61 Reduced 12.4%	431 $3,000
Q1 2023 May 04, 2023	SELL	$8.36 - $11.37 $158 - $216	-19 Reduced 3.72%	492 $4,000
Q4 2022 Feb 06, 2023	BUY	$7.95 - $9.48 $445 - $530	56 Added 12.31%	511 $4,000
Q3 2022 Nov 09, 2022	SELL	$6.86 - $11.95 $2,154 - $3,752	-314 Reduced 40.83%	455 $4,000
Q2 2022 Aug 04, 2022	BUY	$7.38 - $10.4 $1,365 - $1,924	185 Added 31.68%	769 $6,000
Q1 2022 Apr 14, 2022	SELL	$7.33 - $9.39 $1,048 - $1,342	-143 Reduced 19.67%	584 $5,000
Q4 2021 Feb 14, 2022	BUY	$7.9 - $10.19 $3,436 - $4,432	435 Added 148.97%	727 $6,000
Q3 2021 Nov 10, 2021	BUY	$8.38 - $10.18 $410 - $498	49 Added 20.16%	292 $3,000
Q2 2021 Aug 04, 2021	SELL	$9.9 - $11.56 $108 - $127	-11 Reduced 4.33%	243 $2,000
Q1 2021 May 05, 2021	SELL	$10.34 - $12.81 $765 - $947	-74 Reduced 22.56%	254 $3,000
Q4 2020 Feb 04, 2021	BUY	$8.61 - $11.04 $1,231 - $1,578	143 Added 77.3%	328 $3,000
Q3 2020 Nov 09, 2020	BUY	$8.57 - $12.69 $591 - $875	69 Added 59.48%	185 $2,000
Q2 2020 Aug 06, 2020	SELL	$8.12 - $13.12 $32 - $52	-4 Reduced 3.33%	116 $1,000
Q4 2019 Feb 07, 2020	BUY	$6.53 - $10.72 $130 - $214	20 Added 20.0%	120 $1,000
Q2 2019 Aug 08, 2019	SELL	$8.12 - $15.72 $48 - $94	-6 Reduced 5.66%	100 $1,000
Q1 2019 May 10, 2019	BUY	$15.58 - $20.01 $93 - $120	6 Added 6.0%	106 $2,000
Q2 2017 Aug 09, 2017	BUY	N/A	100	100 $3,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.